Stanley Druckenmiller's OLMA Position Overview
Stanley Druckenmiller (via Duquesne Family Office LLC) currently holds 986,827 shares of Olema Pharmaceuticals, Inc. (OLMA) worth $14.71 M, representing 0.44% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Stanley Druckenmiller has initiated a new position in OLMA, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Stanley Druckenmiller's Olema Pharmaceuticals (OLMA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Olema Pharmaceuticals (OLMA) Trades by Stanley Druckenmiller
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +986,827 | New Buy | 986,827 | $14.91 |
Stanley Druckenmiller's Olema Pharmaceuticals Investment FAQs
Stanley Druckenmiller first purchased Olema Pharmaceuticals, Inc. (OLMA) in Q1 2026, acquiring 986,827 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Stanley Druckenmiller has held Olema Pharmaceuticals, Inc. (OLMA) for 1 quarters since Q1 2026.
Stanley Druckenmiller's largest addition to Olema Pharmaceuticals, Inc. (OLMA) was in Q1 2026, adding 986,827 shares worth $14.71 M.
According to the latest 13F filing for Q1 2026, Stanley Druckenmiller's firm, Duquesne Family Office LLC, owns 986,827 shares of Olema Pharmaceuticals, Inc. (OLMA), valued at approximately $14.71 M.
As of the Q1 2026 filing, Olema Pharmaceuticals, Inc. (OLMA) represents approximately 0.44% of Stanley Druckenmiller's publicly disclosed stock portfolio, making it one of their key holdings.
Stanley Druckenmiller's peak holding in Olema Pharmaceuticals, Inc. (OLMA) was 986,827 shares, as reported at the end of Q1 2026.